Ecovyst ECVT
- Market cap
- $1.1B
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 1.2×
- EV/EBIT
- 18.0×
- Revenue, 12 months
- $869.3M
- +40% on a year ago
- Net margin
- −7.1%
- Free cash flow yield
- 7.7%
Ecovyst trades at 1.2× sales. Its trailing earnings are negative, so it has no PE. Revenue was $869.3M over the last twelve months, up 40% on a year earlier with a −7% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $173.3M−26% | $172.8M−5% | $141.6M−12% | $154M−16% | $153.9M−11% | $148.9M−14% | $143.1M+1% | $176.1M+14% | $204.9M+33% | $199.4M+34% | $215M+50% | $250M+42% | |
| Cost of revenue | $120.1M−27% | $125.5M−6% | $121.3M−3% | $129.2M+5% | $108.7M−10% | $128M+2% | $124M+2% | $135.9M+5% | $152.8M+41% | $152.7M+19% | $178.5M+44% | $200.1M+47% |
| Gross profit | $53.2M−21% | $47.3M−4% | $33.2M−9% | $42M−31% | $45.1M−15% | $43M−9% | $19.1M−43% | $40.2M−4% | $52.1M+15% | $46.8M+9% | $36.4M+91% | $49.8M+24% |
| SG&A | $16.9M−21% | $19.8M+13% | $21.6M+2% | $22.7M+6% | $15.2M−10% | $19.6M−1% | $16.5M−24% | $17.6M−22% | $15.7M+3% | $16.2M−17% | $19.1M+16% | $17.4M−2% |
| $31.9M−17% | $22.8M+3% | $13.5M+56% | $21.7M−35% | $27.5M−14% | $22.4M−1% | −$981K | $15.8M−27% | $28.3M+3% | $21.8M−3% | $12.5M | $19.4M+23% | |
| Interest expense | $11.8M+24% | $13.9M+35% | $13.4M+36% | $12.9M+41% | $7.9M−33% | $11.8M−15% | $8.4M−38% | $8.5M−34% | $8.4M+6% | $9.4M−20% | $3.2M−62% | $3.5M−59% |
| Pre-tax income | $24.5M−19% | $23.1M−5% | $2.4M | $11.4M−67% | $19.4M−21% | −$37.5M | −$10.4M | $7M−38% | $20.6M+6% | $8.2M | $9.3M | $14.9M+112% |
| $7.9M−12% | −$6.8M | $1.2M+25% | $3.1M−65% | $4.6M−42% | −$8.3M+22% | −$2.2M | $2M−35% | $20.2M+339% | −$476K−94% | $3.6M | $4.2M+108% | |
| Net income | $16.6M−22% | $29.9M+19% | $1.2M | $8.3M−68% | $14.3M−14% | −$30.4M | −$3.6M | $6M−28% | −$79.3M | $5.7M | $4.3M | $7.9M+31% |
| $0.14−13% | $0.26+30% | $0.01 | $0.07−68% | $0.12−14% | −$0.26 | −$0.03 | $0.05−29% | −$0.69 | $0.05 | $0.04 | $0.07+40% | |
| 117.4M−13% | 116.7M−9% | 117.5M−4% | 117.6M−2% | 117.2M−0% | 117.5M+1% | 117.3M−0% | 116.5M−1% | 114.9M−2% | 114.5M−3% | 111.8M−5% | 110.8M−5% |
EPS, diluted: Q4 FY23 and Q4 FY24: quarter's net income to common over its shares, to the cent.
Diluted shares: Q4 FY23: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Chemicals nearest Ecovyst's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| ECVTEcovyst | $1.1B | n/m | 21.4× | 1.2× | +40% | −7.1% | |
| CRONCronos | $1.2B | 16.8× | 25.0× | 6.9× | +37% | 39.1% | |
| FTKFlotek Industries | $865.7M | 24.1× | 27.6× | 3.0× | +37% | 13.0% | |
| ROGRogers | $2.2B | 71.4× | 34.3× | 2.7× | +5% | 3.7% | |
| NGVTIngevity | $2.4B | 47.4× | 19.9× | 2.1× | −4% | 4.7% | |
| IOSPInnospec | $2.4B | 20.1× | 22.3× | 1.3× | +3% | 6.6% | |
| FULFuller H B | $2.7B | 13.8× | 22.9× | 0.8× | +1% | 5.6% | |
| WDFCWD 40 | $2.9B | 32.3× | 39.2× | 4.2× | +10% | 13.2% | |
| AVNTAvient | $3.8B | 22.2× | 20.2× | 1.1× | +2% | 5.1% | |
| CBTCabot | $3.8B | 20.8× | 14.4× | 1.0× | −5% | 5.2% | |
| CSWCSW Industrials | $4.8B | 40.6× | 34.7× | 4.1× | +28% | 10.3% | |
| Peer median | $2.6B | 23.2× | 23.9× | 2.4× | +4% | 6.1% |
More on Ecovyst
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #2of 37Chemicals stocks with the fastest revenue growth
- #8of 26Chemicals stocks with the highest free cash flow yield
Its groups
About
- Industry
- Chemicals
- Sector
- Basic Materials
Valuation data, not investment advice. Prices as of .